Glaucoma Screening to Enhance At-Risk Californians' Health
Recruiting · NCT06854198 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, San Francisco
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.
Who can take part
Inclusion criteria
- Black people aged 50 years or older
- Hispanic people aged 65 years or older
- People with diabetes aged 50 years or older
- Must have been seen at the Federally Qualified Health Center (FQHC) within the past month
Exclusion criteria
- Patients without a valid phone number or mailing address
- Patients who have had an optometry appointment within the past year
Where it is running
2 locations listed across 1 US state.
- Baywell Health - Oakland, California, United States
- University of California, San Francisco - San Francisco, California, United States